Hepatitis C in Developing Countries

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1. Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinoma Presents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6 Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C

Produk Detail:

  • Author : Sanaa M. Kamal
  • Publisher : Academic Press
  • Pages : 278 pages
  • ISBN : 0128032340
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKHepatitis C in Developing Countries

Hepatitis C in Developing Countries

Hepatitis C in Developing Countries
  • Author : Sanaa M. Kamal
  • Publisher : Academic Press
  • Release : 23 November 2017
GET THIS BOOKHepatitis C in Developing Countries

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health

CDC Yellow Book 2020

CDC Yellow Book 2020
  • Author : CENTERS FOR DISEASE CONTROL AND PREVENTION. (CDC)
  • Publisher : Oxford University Press, USA
  • Release : 11 June 2019
GET THIS BOOKCDC Yellow Book 2020

The definitive reference for travel medicine, updated for 2020! "A beloved travel must-have for the intrepid wanderer." -Publishers Weekly "A truly excellent and comprehensive resource." -Journal of Hospital Infection The CDC Yellow Book offers everything travelers and healthcare providers need to know for safe and healthy travel abroad. This 2020 edition includes: · Country-specific risk guidelines for yellow fever and malaria, including expert recommendations and 26 detailed, country-level maps · Detailed maps showing distribution of travel-related illnesses, including dengue, Japanese encephalitis, meningococcal meningitis, and schistosomiasis ·

Hepatitis and Liver Cancer

Hepatitis and Liver Cancer
  • Author : Institute of Medicine,Board on Population Health and Public Health Practice,Committee on the Prevention and Control of Viral Hepatitis Infections
  • Publisher : National Academies Press
  • Release : 23 May 2010
GET THIS BOOKHepatitis and Liver Cancer

The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have

Advances in Treatment of Hepatitis C and B

Advances in Treatment of Hepatitis C and B
  • Author : Naglaa Allam
  • Publisher : BoD – Books on Demand
  • Release : 08 March 2017
GET THIS BOOKAdvances in Treatment of Hepatitis C and B

As in many areas of medicine, treatment of viral hepatitis has seen an acceleration of change driven by new therapies and evolving technology. Thanks to the direct-acting antiviral agents (DAAs), the era of HCV eradication and cure has begun. As regards to hepatitis B therapy, potent antiviral drugs for suppression of viral replication are available, new research activities to enhance eradication are visible, and these may influence clinical practice in the coming years. This book covers the latest advances in

Hepatitis C

Hepatitis C
  • Author : Imran Shahid
  • Publisher : BoD – Books on Demand
  • Release : 10 October 2018
GET THIS BOOKHepatitis C

The propagation of hepatitis C from acute to chronic infection and afterward to end-stage liver diseases (hepatic fibrosis, cirrhosis, and hepatocellular carcinoma) involves a highly orchestrated series of molecular and cellular events, including a plethora of genes and cell signaling cascades. The treatment paradigms was revolutionized after the development and approval of all oral interferon-free direct-acting antivirals achieving higher sustained virologic response rates in treated individuals. This book pragmatically overviews the intricate interplay between viral and host factors during hepatitis

Practical Management of Chronic Viral Hepatitis

Practical Management of Chronic Viral Hepatitis
  • Author : Gaetano Serviddio
  • Publisher : BoD – Books on Demand
  • Release : 29 May 2013
GET THIS BOOKPractical Management of Chronic Viral Hepatitis

Continuous acquisition of new knowledge in Medicine is essential to ensure progression in diagnostics and therapeutics. In the last decade the discipline of Hepatology has achieved critical progress in the treatment of viral hepatitis. The present book has been realized by a team of experts daily facing clinical problems in the prevention and management of liver diseases and has been designed for a global readership to offer some practical tips to physicians who want update their level of practice in

Eliminating the Public Health Problem of Hepatitis B and C in the United States

Eliminating the Public Health Problem of Hepatitis B and C in the United States
  • Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Population Health and Public Health Practice,Committee on a National Strategy for the Elimination of Hepatitis B and C
  • Publisher : National Academies Press
  • Release : 01 June 2016
GET THIS BOOKEliminating the Public Health Problem of Hepatitis B and C in the United States

Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to

Hepatitis B and C

Hepatitis B and C
  • Author : Anonim
  • Publisher : BoD – Books on Demand
  • Release : 08 April 2020
GET THIS BOOKHepatitis B and C

This book on Hepatitis B and C contains very useful and recent information about the general characteristics of these common types of chronic liver infections. Referred to as Hepatitis B, there are three chapters describing the main epidemiological, clinical, therapeutic, and prognosis aspects. The molecular variants for HBsAg, its genotyping, and their clinical implications are fully analyzed. The implications of coinfection Hepatitis B and C in HIV patients and their treatment are described. In relation to Hepatitis C, there are

A National Strategy for the Elimination of Hepatitis B and C

A National Strategy for the Elimination of Hepatitis B and C
  • Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Population Health and Public Health Practice,Committee on a National Strategy for the Elimination of Hepatitis B and C
  • Publisher : National Academies Press
  • Release : 30 June 2017
GET THIS BOOKA National Strategy for the Elimination of Hepatitis B and C

Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to

Hepatitis C

Hepatitis C
  • Author : Anonim
  • Publisher : Elsevier
  • Release : 09 October 2000
GET THIS BOOKHepatitis C

The anticipated encore volume of the Biomedical Research Reports Series, Hepatitis C is the first book that offers comprehensive and up-to-date coverage of this "silent epidemic." The subject matter ranges from basic science to clinical medicine, with contributions from more than 30 international experts in the field. This important new book details the hepatitis C virus and the disease that it causes, including its prevalence, means of spread, symptoms, complications, natural history, prevention, and therapy. The editors, T. Jake Liang, M.

Thalassemia and Other Hemolytic Anemias

Thalassemia and Other Hemolytic Anemias
  • Author : Isam Jaber Al-Zwaini
  • Publisher : BoD – Books on Demand
  • Release : 11 July 2018
GET THIS BOOKThalassemia and Other Hemolytic Anemias

Thalassemia is a very common disease first described by pediatrician Thomas Benton Cooley in 1925 who described it in a patient of Italian origin. At that time, it was designated as Cooley's anemia. George Hoyt Whipple, a Nobel prize winner, and W. L. Bradford, a professor of pediatrics at the University of Rochester, coined the term thalassemia in 1936, which in Greek means anemia of the sea (Thalassa means "sea", and emia means "blood"), due to the fact that it is very

HCV and Related Liver Diseases

HCV and Related Liver Diseases
  • Author : Kiwamu Okita
  • Publisher : Springer Science & Business Media
  • Release : 06 December 2012
GET THIS BOOKHCV and Related Liver Diseases

More than 2 million people in Japan have chronic hepatitis C and many of them will lose their lives to liver cirrhosis or complications of hepatocellular carcinoma. Hepatitis C virus-related diseases are a serious concern both in developing countries and in Japan and the United States, where the number of patients is also in the millions. Therapeutic modalities recently developed in Japan, including interferon therapy and nutritional supportive therapy, are gaining worldwide acceptance. At this critical juncture, HCV and Related Liver

Saliva Protection and Transmissible Diseases

Saliva Protection and Transmissible Diseases
  • Author : Crispian Scully,Jacobo Limeres Posse,Pedro Diz Dios
  • Publisher : Academic Press
  • Release : 19 July 2017
GET THIS BOOKSaliva Protection and Transmissible Diseases

Saliva Protection and Transmissible Diseases provides a review of saliva protection, raising debate on micro-organisms potentially transmissible in saliva, and also considering the evidence on diseases that may be transmitted by kissing. Saliva is a complex body fluid essential to health, especially mastication, swallowing and speech, and hyposalivation can lead to dysfunction and even infection. More serious pathogens, such as herpes viruses and papillomaviruses can be conveyed by kissing, as can potentially lethal micro-organisms present in some saliva, such as

The Political Economy of HIV/AIDS in Developing Countries

The Political Economy of HIV/AIDS in Developing Countries
  • Author : Benjamin Coriat
  • Publisher : Edward Elgar Publishing
  • Release : 01 January 2008
GET THIS BOOKThe Political Economy of HIV/AIDS in Developing Countries

The issue of universal and free access to treatment is now a fundamental goal of the international community. Based on original data and field studies from Brazil, Thailand, India and Sub-Saharan Africa under the aegis of ANRS (the French nationalagency for research on Aids and viral hepatitis, this timely and significant book both assesses the progress made in achieving this objective and presents a rigorous diagnosis of the obstacles that remain. Placing particular emphasis on the constraints imposed by TRIPS

Hepatitis C Virus: From Molecular Virology to Antiviral Therapy

Hepatitis C Virus: From Molecular Virology to Antiviral Therapy
  • Author : Ralf Bartenschlager
  • Publisher : Springer Science & Business Media
  • Release : 12 March 2013
GET THIS BOOKHepatitis C Virus: From Molecular Virology to Antiviral Therapy

Hepatitis C virus (HCV), a major causative agent of chronic liver disease, is spread throughout the world and around 170 million people are persistently infected. In this volume, world-leading experts in the field of HCV research have compiled the most recent scientific advances to provide a comprehensive and very timely overview of the various facets of HCV. The book starts with a discussion of the possible origin of HCV and its spread among the human population. The focus of the subsequent